Citeline Podcasts
1,366 episodes - English - Latest episode: 3 days ago - ★★★★★ - 24 ratingsCiteline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
The Push For OTC Birth Control With Victoria Nichols
June 28, 2022 21:16 - 19 minutes - 18.5 MBOn this episode, HBW speaks to Victoria Nichols, project director of Free the Pill. Operated by Ibis Reproductive Health, a nonprofit advocacy organization focused on advancing sexual and reproductive autonomy worldwide, Free the Pill is a campaign supporting increased oral contraceptive access through OTC birth control pills. Ibis Reproductive is also working with Perrigo to submit an Rx-to-OTC switch NDA later this year for its progestin daily oral contraceptive. In the wake of the Supreme...
Scrip’s Five Must-Know Things – 27 June 2022
June 27, 2022 01:58 - 14 minutes - 32.3 MBScrip’s Five Must-Know Things – 27 June 2022 by Citeline
Medtech Monthly, Ep. 1: Quality Vs. Compliance
June 24, 2022 21:17 - 1 hour - 35.6 MBMedtech Monthly is here! Check out the first episode of our new podcast series: It's a knock-down (not really), drag-out (not really), freewheelin' (very much so) conversation about quality versus compliance, with the US FDA's Cisco Vicenty in one corner, and former FDA compliance chief Steve Silverman in the other. Medtech Insight articles addressing topics discussed in this episode: • Speaking Of Medtech, Ep. 9: The Case For Compliance • Speaking Of Medtech, Ep. 8: Medical Device Quality • ...
Post-ASCO Podcast
June 24, 2022 11:56 - 36 minutes - 17.4 MBDatamonitor Healthcare’s oncology team discuss key results from ASCO 2022 Supporting links: post-ASCO report https://service.datamonitorhealthcare.com/hkc/thought-leadership/article239222.ece?sg=article Other platforms in addition to SoundCloud: Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836 Google Podcasts – https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZXJzOjEwNjU1NDkyOC9zb3VuZHMucnNz...
Report Digest: Deep Brain and Vagus Nerve Stimulation
June 22, 2022 13:10 - 14 minutes - 8.64 MBIn this episode of Report Digest, reporter Barnaby Pickering speaks to analyst Mike Carmody about Meddevicetracker’s recent report on deep brain and Vagus nerve stimulation. The two discuss market players, recent tech developments and future potential for the market.
파이낸스 워치: 글로벌 제약바이오업계, 올해 들어 현금 비중 늘리고 인력 감축 파이낸스 워치: 올해1분기 VC의 제약바이오 투자 비중 압도적으로 증가
June 21, 2022 23:49 - 4 minutes - 9.94 MBScrip Intelligence에 실린 파이낸스 워치 (Finance Watch)기사의 요약 내용으로 글로벌 제약바이오업계가 올해 들어 현금 비중을 늘리고 인력 감축에 나서고 있으며, 올해 1분기 글로벌 시장에서 전체 제약바이오 투자 규모는 줄었지만 벤쳐캐피탈 (VC)의 제약바이오 투자 비중이 압도적으로 증가했다는 내용입니다. https://scrip.pharmaintelligence.informa.com/SC146403/Finance-Watch-More-Job-Cuts-As-Companies-Prioritize-Cash-Conservation https://scrip.pharmaintelligence.informa.com/SC146493/Finance-Watch-Venture-Capital-Dominates-Biopharma-Funding-So-Far-In-2022
Digital Health Roundup: A Mixed Bag Of Exec Interviews; Femtech; Robotics; Digital OR; Wearables
June 21, 2022 22:29 - 6 minutes - 4.13 MBIn this month’s Digital Health roundup, Medtech Insight’s Marion Webb discusses her deep-dive article on menopause with leading experts in this rising industry and Barnaby Pickering highlights UK-based Proximie, which developed a web-based platform that allows surgeons and other clinical experts to collaborate virtually in the operating suite. The company recently raised $80m in a series C round. Listen to the podcast via the player below: Medtech Insight articles addressing topics discuss...
Scrip’s Five Must-Know Things – 20 June 2022
June 20, 2022 01:45 - 14 minutes - 33.5 MBScrip’s Five Must-Know Things – 20 June 2022 by Citeline
3分で解説 世界のファーマ 第2回 FDAの新しい品質管理指標 QMMとは？
June 15, 2022 00:59 - 3 minutes - 7.26 MB世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。 For listeners in the pharma industry, we deliver a summarized insight from Scrip and Pink Sheet in Japanese, one story at a time. 今回取り上げた記事はこちら The article for this episode is: US FDA’s ‘Mature’ Approach To Quality: ‘Encourage More, Punish Less’ （邦題意訳「FDA、薬の品質対策に新戦略 “ムチよりアメ”のQMM制度とは？」） https://pink.pharmaintelligence.informa.com/PS146314/US-FDAs-Mature-Approach-To-Quality-Encourage-More...
Scrip’s Five Must-Know Things – 13 June 2022
June 13, 2022 01:48 - 14 minutes - 34.2 MBScrip’s Five Must-Know Things – 13 June 2022 by Citeline
Interview With Luzsana CEO Scott Filosi And CMO Joseph Eid
June 09, 2022 00:18 - 56 minutes - 64.2 MBJoin Brian Yang in this wide-ranging interview with top executives from Jiangsu Hengrui’s US subsidiary Luzsana, on topics ranging from innovation to going global, US approvals of China-made drugs and China’s regulatory harmonization efforts.
Reusable Packaging For Consumer Health Goods With Annika Greve
June 08, 2022 21:29 - 23 minutes - 22 MBIn this episode, I speak to Annika Greve from Loop and Terracycle about the work that those companies do reducing waste across industries. Loop works with companies like Bausch+Lomb to create packaging that can be bought, used, and then dropped off in big box stores where consumers regularly shop. We spoke about how greenwashing from companies can harm consumer trust in the industry, and how the relatively recent habit of disposability will ultimately drive how companies switch to sustainable...
Scrip’s Five Must-Know Things – 6 June 2022
June 06, 2022 02:31 - 14 minutes - 33.4 MBScrip’s Five Must-Know Things – 6 June 2022 by Citeline
Device Week, 2 June 2022 – Robot Blood Draws? Diabetes Upheavals
June 02, 2022 20:53 - 8 minutes - 5.1 MBIn this edition of Device Week, Medtech Insight’s Barnaby Pickering discusses recent developments in the highly competitive continuous glucose monitoring space and editor Marion Webb explains the application of robotics to common blood sampling. The archive of Medtech Insight's Device Week and the rest of Informa Pharma Intelligence’s podcasts are available on the Pharma Intelligence channel on Apple Podcasts, Google Podcasts, SoundCloud, TuneIn, and Spotify Podcasts: https://medtech.pharmai...
Speaking Of Medtech, Ep. 9: The Case For Compliance
June 02, 2022 19:25 - 19 minutes - 22.3 MBSpeaking Of Medtech, Ep. 9: The Case For Compliance In this episode of Speaking Of Medtech: Over the past decade or so the US FDA and many device makers have been advocating for quality over compliance, but what if promoting compliance was seen as a good goal for the medtech industry? Medtech Insight articles addressing topics discussed in this episode: • Opinion: The Case For Quality – AND Compliance https://medtech.pharmaintelligence.informa.com/MT145406/Opinion-The-Case-For-Quality--AND-Co...
보스턴으로 몰리는 한국 제약바이오업계의 기회와 도전
June 01, 2022 00:43 - 4 minutes - 9.91 MBTitle: Korean-language Scrip article summary 보스턴으로 몰리는 한국 제약바이오업계의 기회와 도전 (Korean Biopharmas Rush To Boston: What Are The Challenges And Opportunities?) Description: 최근 국내 제약바이오사들의 미국 진출이 더욱 활발해지고 있는 이유와 이 기업들이 미국에 진출할 때 특히 어떤 어려움을 겪고 있는 지에 대한 Scrip Intelligence의 인터뷰 기사를 요약한 내용입니다. https://scrip.pharmaintelligence.informa.com/SC146422/Korean-Biopharmas-Rush-To-Boston-What-Are-The-Challenges-And-Opportunities
Ellie Davenport, Summer Colling, and Kripa Krishnan discuss the psychiatric disorder market
May 30, 2022 21:39 - 35 minutes - 15.9 MBEllie Davenport, Summer Colling, and Kripa Krishnan discuss the psychiatric disorder market and outlook, with a focus on schizophrenia, bipolar, and major depressive disorder. Schizophrenia disease analysis report and forecast https://service.datamonitorhealthcare.com/hkc/disease/central-nervous-system/psychiatry/schizophrenia/disease-analysis/article216769.ece Bipolar disease analysis report and forecast https://service.datamonitorhealthcare.com/hkc/disease/central-nervous-system/psychia...
Scrip’s Five Must-Know Things – 30 May 2022
May 30, 2022 02:37 - 13 minutes - 30.5 MBScrip’s Five Must-Know Things – 30 May 2022 by Citeline
Pink Sheet Podcast Crossover Special: Assessing FDA Commissioner Robert Califf’s First 100 Days
May 27, 2022 17:11 - 1 hour - 41.1 MBReporters and editors from the Pink Sheet and sister publications covering the medical device and health, beauty and wellness sectors look at Califf’s goals, accomplishments and trials during the early days of his second term.
Three-Minute Japanese-Language Article Summary
May 25, 2022 07:18 - 3 minutes - 7.86 MBJapanese-language summary insights from Scrip and Pink Sheet, a selected story at a time. 世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。 The article for this episode is: 今回取り上げた記事はこちら Is It Tougher To Conduct Decentralized Trials In The EU? ‘Don’t Fall Prey To Negative Narrative’ 邦題意訳「EU圏ではDCTがやりにくい？ ネガティブな思い込みの盲点」 https://pink.pharmaintelligence.informa.com/PS146158/Is-It-Tougher-To-Conduct-Decentralized-Trials-In-The-EU-Dont-Fall-P...
OTC Monograph Reform: A Conversation With CHPA’s Barbara Kochanowski and David Spangler
May 23, 2022 17:09 - 23 minutes - 16.5 MBIn this episode, HBW speaks to Barbara Kochanowski and David Spangler from the Consumer Healthcare Products Association about OTC monograph reform. The old OTC monograph system was reimagined as a part of the 2020 CARES act passed in the early stages of the pandemic. Designed to streamline and modernize the OTC monograph system, the results have been slow as the FDA has had most of its attention on the pandemic. However, as the agency hires more staff, Spangler says that we should expect to s...
Scrip’s Five Must-Know Things – 23 May 2022
May 23, 2022 02:32 - 14 minutes - 33.4 MBScrip’s Five Must-Know Things – 23 May 2022 by Citeline
EU MedTech Forum 2022: Regulatory Predictability Impacts Renewed Calls For Devices Agency
May 20, 2022 13:58 - 26 minutes - 11.6 MBEU MedTech Forum 2022: Regulatory Predictability Impacts Renewed Calls For Devices Agency by Citeline
A Clinical Trial Hot Spot: Australia’s Attractions For Korean Firms
May 19, 2022 01:00 - 17 minutes - 40 MBAusbiotech’s CEO and the Senior Trade and Investment Commissioner at the Australian Embassy in South Korea talk to Scrip’s Jung Won Shin on the sidelines of Bio Korea 2022 about what makes Australia an attractive clinical trial destination for Korean and other foreign firms, as well as collaborations and other opportunities between the two countries.
Cybin CEO: Big Pharma Can No Longer Sit On The Sidelines In Psychedelics
May 17, 2022 11:56 - 13 minutes - 6.34 MBCybin CEO: Big Pharma Can No Longer Sit On The Sidelines In Psychedelics by Citeline
Digital Health Roundup – AI Trends In Medtech; Exec Chats; FDA’s Digital Health Guru Steps Down
May 16, 2022 19:51 - 8 minutes - 5.09 MBIn this month’s podcast, Medtech Insight's Reed Miller discusses iRhythm’s CEO Quentin Blackford’s vision for the company as it plans for expanding its remote cardiac monitoring and arrythmia diagnostics market. Marion Webb highlights conversations with ORCHA’s clinical lead Fatima Ahmed on the shortfall of trustworthy femtech apps and with medical robotic authority Moshe Shoham on the future of robotics. Barnaby Pickering introduces SpectralMD’s developed AI-augmented imaging system and NHS’...
Scrip’s Five Must-Know Things – 16 May 2022
May 16, 2022 02:33 - 14 minutes - 33.6 MBScrip’s Five Must-Know Things – 16 May 2022 by Citeline
Pink Sheet Podcast: FDA User Fee Bill Mark-Up, Postmarket Quality Requirements, Fewer Adcom Meetings
May 13, 2022 16:01 - 24 minutes - 15.4 MBPink Sheet reporter and editors discuss the first mark-up of the House FDA user fee bill, the likelihood of more postmarketing quality requirements for drug manufacturers, and the significance of the shrinking number of FDA advisory committee meetings.
How Ex-Janssen India Chief Is Steering Bharat Serums’ Ambitions In Women’s Health
May 13, 2022 06:18 - 40 minutes - 23.4 MBSanjiv Navangul, managing director and CEO, Bharat Serums and Vaccines, outlines, in a wide ranging interview, the firm’s gameplan to establish itself as a “force to reckon with” in women’s health - it goes beyond drugs and encompasses devices and potentially digital therapeutics as well. The former Janssen India chief also weighs in on the worrying industry-wide input cost escalation scenario and supply chain turbulence.
Report Digest: Discussing What's Going On With Prostate Cancer Diagnosis And Treatment
May 12, 2022 12:18 - 25 minutes - 12.3 MBReport Digest: Discussing What's Going On With Prostate Cancer Diagnosis And Treatment by Citeline
Scrip’s Five Must-Know Things – 9 May 2022
May 09, 2022 00:59 - 12 minutes - 28.1 MBScrip’s Five Must-Know Things – 9 May 2022 by Citeline
Pink Sheet Podcast: House User Fee Bill, Push For OTC Naloxone, SCOTUS Overturning Roe v. Wade
May 06, 2022 16:33 - 44 minutes - 27.9 MBPink Sheet reporter and editors and HBW Insight editor discuss FDA reforms in the new user fee reauthorization bill, additional industry inducements to market OTC naloxone, and the impact of a Supreme Court’s potential overturning of Roe v. Wade on the agency.
The Landscape Of Naloxone Access With HRT’s Michael Hufford
May 06, 2022 14:48 - 27 minutes - 23.6 MBIn this episode, HBW Insight speaks to Michael Hufford, co-founder and CEO of Harm Reduction Therapeutics about the inaccessibility of naloxone, a life-saving opioid overdose antidote. Hufford unpacks on the history of naloxone access and explains why standing orders aren’t as helpful as they seem. We also explore the incentives for companies currently producing prescription naloxone to make the switch to OTC status—and why many of them have chosen not to. While the financial incentive may no...
Which COVID Trends Are Here To Stay? With IQVIA Consumer Health’s Prasanna Pitale
May 03, 2022 10:07 - 31 minutes - 71.6 MBIn this episode, HBW Insight chats with IQVIA Consumer Health’s Prisana Pitale about research the organisation has done on the recent self-care trends that will endure after COVID. Commissioning an external organisation to speak to industry leaders, Pitale points to wellness and prevention, Rx-to-OTC switch and naturals as drivers of long-term change in global consumer health markets. We also dig a bit deeper into sustainability and artificial intelligence, which we agree are important disrup...
Pink Sheet Podcast: Young Children’s COVID Vaccines, Aduhelm Coverage Criticism, McKinsey Conflicts
April 29, 2022 16:30 - 37 minutes - 25.5 MBPink Sheet reporter and editor discuss next steps in the development of COVID-19 vaccines for young children, complaints about CMS’s coverage decision for Aduhelm, and the congressional investigation of McKinsey’s FDA conflicts of interest.
The EU HTA Regulation: How It Threatens Device Launches And Where The Solutions Lie
April 29, 2022 10:23 - 28 minutes - 13.3 MBThe EU HTA Regulation: How It Threatens Device Launches And Where The Solutions Lie by Citeline
CEO Podcast – CANbridge’s James Xue Talks To Scrip On Plans And Strategy
April 27, 2022 03:46 - 1 hour - 30.4 MBThe CEO of Chinese biotech CANbridge talks to Scrip’s Brian Yang on a broad range of topics related to the company’s plans and strategy in this new series of audio interviews with senior biopharma executives in China.
Scrip’s Five Must-Know Things – 25 April 2022
April 25, 2022 02:07 - 13 minutes - 31.7 MBScrip’s Five Must-Know Things – 25 April 2022 by Citeline
Exploring The Intersection Of Skincare, AI, And Business With Sampo Parkkinen
April 22, 2022 20:56 - 23 minutes - 22.1 MBIn this episode, HBW speaks to AI technology expert Sampo Parkkinen, CEO of Revieve. We discuss the importance of customization for businesses and consumers, the future of AI in the cosmetics industry, and the younger demographics that are most interested in brand personalization. Finally, we talk about Revieve’s space in the metaverse, and how businesses can leverage new technology to build relationships with their consumers.
Pink Sheet Podcast: COVID-19 Vaccine Boosters, Clinical Trial Diversity, FDA Returns To The Office
April 22, 2022 16:23 - 32 minutes - 19.5 MBPink Sheet reporter and editors discuss CDC advisors’ views on COVID-19 vaccine booster policy, new FDA guidance to promote clinical trial diversity, and what some FDA employees are finding when they return to the White Oak headquarters.
Zydus Lifesciences MD Sharvil Patel On Rare Disease Focus, New Corporate Identity, COVID Vaccine
April 21, 2022 04:06 - 26 minutes - 30 MBZydus Lifesciences’ (formerly Cadila Healthcare) managing director Sharvil Patel speaks to Scrip on a host of topics ranging from a focus on rare diseases to a fresh corporate identity and plans for launch of a two-dose version of the world’s first plasmid DNA vaccine that it developed against COVID-19. Patel also talks about his personal business journey as well as the importance of building organizational agility to deal with uncertainty that companies are increasingly having to deal with.
Q1 Consumer Health Earnings Preview, With HBW’s Malcom Spicer And Tom Gallen
April 19, 2022 09:45 - 29 minutes - 66.7 MBIn this episode, HBW Insight editors look ahead to Q1 sales and earnings reports of the world’s largest consumer healthcare companies. We reflect on what has happened in the last 12 months during the COVID-19 pandemic, and what the next few months might bring for industry. The return of cough and cold, inflation and the war in Ukraine and OTC business spin outs are all major trends shaping the market right now.
Scrip’s Five Must-Know Things – 18 April 2022
April 18, 2022 02:09 - 13 minutes - 31.2 MBScrip’s Five Must-Know Things – 18 April 2022 by Citeline
Device Week, 13 April 2022 –Miach And Outset Exec Chats; Medtronic Updates Renal Denervation Trials
April 13, 2022 20:58 - 11 minutes - 6.73 MBIn this edition of Device Week, Medtech Insight’s Marion Webb reviews her recent interviews with Martha Shadan, the CEO of Miach Orthopedics, and Outset Medical’s CEO Leslie Trigg. Reed Miller has an update on Medtronic’s long-awaited renal denervation technology. Listen to the podcast via the player below: The archive of Medtech Insight's Device Week and the rest of Informa Pharma Intelligence’s podcasts are available on the Informa Pharma Intelligence channel on Apple Podcasts, Google Podc...
Digital Health Roundup – March Mad About Medtech Conferences; Telehealth Legislation
April 12, 2022 22:36 - 8 minutes - 4.68 MBIn this month’s podcast, Medtech Insight's Reed Miller reports on Amazon’s new deal with North Carolina-Triangle company Thread Research to create decentralized clinical trials and HIMSS coverage. Marion Webb discusses highlights from her live coverage at the AAOS and Sensors Summit conferences. Medtech Insight articles addressing topics discussed in this episode: Silicon Valley Bank Advisor Predicts 2022 Will Be Year For Healtech, Massive Consolidation https://medtech.pharmaintelligence.in...
Scrip’s Five Must-Know Things – 11 April 2022
April 11, 2022 02:17 - 13 minutes - 30.7 MBScrip’s Five Must-Know Things – 11 April 2022 by Citeline
Sustainability In The U.S. Cosmetics Industry With Ryan Nelson
April 08, 2022 14:32 - 43 minutes - 37.9 MBIn this episode, HBW Insight takes a bird’s eye view of sustainability in the cosmetics industry with HBW Insight Executive Editor Ryan Nelson. We discuss the drivers of sustainability efforts such as consumer demand for more eco-friendly products and the growing social consciousness about climate. We also discuss what steps companies are taking to make their products more sustainable, how the beauty industry is using third party regulatory groups to combat greenwashing, as well as the legisl...
Scrip’s Five Must-Know Things – 4 April 2022
April 04, 2022 03:04 - 13 minutes - 13.6 MBScrip’s Five Must-Know Things – 4 April 2022 by Citeline
Device Week, 1 April 2022 – MDUFA V Heads To Capitol Hill
April 01, 2022 21:14 - 7 minutes - 4.19 MBIn this episode of Device Week: US lawmakers grilled FDA device center director Jeff Shuren on 30 March about the agency’s approach to putting together the latest user-fee agreement between industry and FDA. Medtech Insight articles addressing topics discussed in this episode: • FDA’s Shuren Grilled About Handling Of MDUFA V At House Hearing • Lifting The Hood On MDUFA V
Pink Sheet Podcast: Amylyx Adcom Take-Aways, FDA Budget Request, Aduhelm Coverage Advocacy
April 01, 2022 16:41 - 36 minutes - 22.4 MBPink Sheet reporter and editors discuss lessons from the FDA’s advisory committee on Amylyx’s ALS drug, the FDA’s proposed FY 2023 budget surge, and the ongoing effort to change the CMS coverage decision on Aduhelm.